Gerstmann-Sträussler-Scheinker Disease with F198S Mutation Induces Independent Tau and Prion Protein Pathologies in Bank Voles.
Alzheimer’s disease
Gerstmann–Sträussler–Scheinker
bank vole
prion
prion-like properties
tau
Journal
Biomolecules
ISSN: 2218-273X
Titre abrégé: Biomolecules
Pays: Switzerland
ID NLM: 101596414
Informations de publication
Date de publication:
21 Oct 2022
21 Oct 2022
Historique:
received:
10
08
2022
revised:
17
10
2022
accepted:
19
10
2022
entrez:
27
10
2022
pubmed:
28
10
2022
medline:
29
10
2022
Statut:
epublish
Résumé
Gerstmann-Sträussler-Scheinker disease (GSS) is a rare genetic prion disease. A large GSS kindred linked to the serine-for-phenylalanine substitution at codon 198 of the prion protein gene (GSS-F198S) is characterized by conspicuous accumulation of prion protein (PrP)-amyloid deposits and neurofibrillary tangles. Recently, we demonstrated the transmissibility of GSS-F198S prions to bank vole carrying isoleucine at 109 PrP codon (BvI). Here we investigated: (i) the transmissibility of GSS-F198S prions to voles carrying methionine at codon 109 (BvM); (ii) the induction of hyperphosphorylated Tau (pTau) in two vole lines, and (iii) compared the phenotype of GSS-F198S-induced pTau with pTau induced in BvM following intracerebral inoculation of a familial Alzheimer's disease case carrying Presenilin 1 mutation (fAD-PS1). We did not detect prion transmission to BvM, despite the high susceptibility of BvI previously observed. Immunohistochemistry established the presence of induced pTau depositions in vole brains that were not affected by prions. Furthermore, the phenotype of pTau deposits in vole brains was similar in GSS-F198S and fAD-PS1. Overall, results suggest that, regardless of the cause of pTau deposition and its relationship with PrP
Identifiants
pubmed: 36291746
pii: biom12101537
doi: 10.3390/biom12101537
pmc: PMC9599806
pii:
doi:
Substances chimiques
Codon
0
Isoleucine
04Y7590D77
Methionine
AE28F7PNPL
Phenylalanine
47E5O17Y3R
Presenilin-1
0
Prion Proteins
0
Prions
0
Serine
452VLY9402
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Références
PLoS Pathog. 2013 Mar;9(3):e1003219
pubmed: 23505374
Mol Neurobiol. 1994 Feb;8(1):41-8
pubmed: 7916191
Sci Rep. 2016 Feb 04;6:20443
pubmed: 26841849
J Virol. 2017 May 12;91(11):
pubmed: 28298604
Acta Neuropathol Commun. 2018 Oct 29;6(1):114
pubmed: 30373672
Mol Cell Biochem. 2008 Mar;310(1-2):49-55
pubmed: 18038270
J Chromatogr B Analyt Technol Biomed Life Sci. 2007 Apr 15;849(1-2):302-6
pubmed: 17008136
Acta Neuropathol. 2021 Aug;142(2):227-241
pubmed: 34128081
Proc Natl Acad Sci U S A. 2020 Dec 8;117(49):31417-31426
pubmed: 33229531
Nat Genet. 1992 Apr;1(1):64-7
pubmed: 1363809
PLoS Pathog. 2006 Feb;2(2):e12
pubmed: 16518470
Brain Res. 1993 Jul 9;616(1-2):325-9
pubmed: 8358624
Emerg Infect Dis. 2019 Jan;25(1):73-81
pubmed: 30561322
Proc Natl Acad Sci U S A. 1996 Jan 23;93(2):744-8
pubmed: 8570627
Proc Natl Acad Sci U S A. 2013 Jun 4;110(23):9535-40
pubmed: 23690619
Vet Microbiol. 2006 Jul 20;115(4):293-301
pubmed: 16621340
J Neuropathol Exp Neurol. 2020 Nov 1;79(11):1141-1146
pubmed: 33000167
PLoS Pathog. 2022 Jun 22;18(6):e1010646
pubmed: 35731839
Sci Rep. 2020 Jan 8;10(1):19
pubmed: 31913327
Nat Cell Biol. 2009 Jul;11(7):909-13
pubmed: 19503072
Nature. 2013 Sep 5;501(7465):45-51
pubmed: 24005412
Acta Neuropathol Commun. 2018 Jan 8;6(1):5
pubmed: 29310723
Nature. 2018 Dec;564(7736):415-419
pubmed: 30546139
Acta Neuropathol. 2017 Aug;134(2):221-240
pubmed: 28349199
Methods Mol Biol. 2012;849:453-71
pubmed: 22528109
J Gen Virol. 2008 Dec;89(Pt 12):2975-2985
pubmed: 19008382
Annu Rev Neurosci. 2015 Jul 8;38:87-103
pubmed: 25840008
Acta Neuropathol. 2002 Oct;104(4):342-50
pubmed: 12200619
Microsc Res Tech. 2000 Jul 1;50(1):10-5
pubmed: 10871543
J Neurol Sci. 2017 Dec 15;383:142-150
pubmed: 29246602
Neurology. 1989 Nov;39(11):1453-61
pubmed: 2573006
J Virol. 2016 Nov 14;90(23):10660-10669
pubmed: 27654300